Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From CorBec Pharmaceuticals Inc.

Exit Strategy, Virtually

The idea behind a virtual company is to put relatively little money to work in a new enterprise, get a program to a go/no go decision point, and then sell it for a big mark-up (if the data looks good) to a more completely infrastructured company. Hillman Ventures has been the main proponent of this strategy but their first "liquidation event" shows that the jury is still out on the strategy's success.

BioPharmaceutical Strategy

Virtuals' Virtues

Hillman Medical Ventures still likes the idea of virtual start-ups, despite their drop in popularity. They've recently created three.

BioPharmaceutical Medical Device
See All
UsernamePublicRestriction

Register